跳至主要内容
临床试验/IRCT20230303057599N2
IRCT20230303057599N2尚未招募3 期

Investigating the effect of alpha lipoic acid on neuropathy in patients with type 2 diabetes.

Tehran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 74 years(—)
性别
All

入选标准

  • Age 18 to 74 years,
  • Type 2 diabetes,
  • duration of diabetes more than one year,
  • presence of peripheral neuropathy (pain) in the examination,
  • symptoms of neuropathy (pain) for at least one month,
  • score more than three in the pain diagnostic questionnaire.

排除标准

  • neurological disease such as MS
  • Severe liver or kidney disease
  • Antioxidant consumption in the last three months
  • The presence of cancer and malignancy and chemotherapy
  • Pregnancy and breastfeeding
  • Peripheral arterial disease
  • diabetic foot ulcer

研究者

相似试验